![PDF] Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2b4f15c4a2ffb07a9a73199f77187bbea685ea9c/27-Table1-1.png "PDF] Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells | Semantic Scholar")
PDF] Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells | Semantic Scholar
5-Aza-2'-deoxycytidine CAS#: 2353-33-5
Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells | Scientific Reports
Intracellular metabolism of 5-AZA-CdR. 5-AZA-CdR is transported into... | Download Scientific Diagram
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons ( P. anubis ) | SpringerLink
Pharmaceuticals | Free Full-Text | Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia | HTML
5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy | Oncogene
Azacitidine | Nature Reviews Drug Discovery
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo
Adverse Effects of 5-Aza-2′-Deoxycytidine on Spermatogenesis Include Reduced Sperm Function and Selective Inhibition of de Novo DNA Methylation | Journal of Pharmacology and Experimental Therapeutics
Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic - ScienceDirect
Metabolism of 5-aza-2′-deoxycytidine (5-AZA-CdR) and 5-azacytidine... | Download Scientific Diagram
Azacitidine - Wikipedia
5-aza-2′Deoxycytidine | SpringerLink
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo
DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B | Molecular and Cellular Biology
Model to explain the effects of 5-aza-dC on DNA methylation and the... | Download Scientific Diagram
Frontiers | Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter | Oncology
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers. - Abstract - Europe PMC
Pharmacology of 5-Aza-2′-deoxycytidine (decitabine) - ScienceDirect
Induction of senescence in cancer cells by 5′-Aza-2′-deoxycytidine: Bioinformatics and experimental insights to its targets - ScienceDirect
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells | Clinical Epigenetics | Full Text
Scheme 2. Preparation of the phosphoramidite of 5-aza-29-deoxycytidine.... | Download Scientific Diagram
Mechanisms of action of AZA and DAC. (A) DAC is incorporated into DNA... | Download Scientific Diagram
Frontiers | Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism | Oncology
DNA Methyltransferase Inhibitors and Their Emerging Role in Epigenetic Therapy of Cancer | Anticancer Research
Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy | Clinical Epigenetics | Full Text
